AtoCap’s CSO, Dr Jennifer Rohn, featured as one of seven inspirational women entrepreneurs

The event, Building Impact Unicorns By Female Founders, was held at Cazenova Capital in London, part of the Schroeders Group, on 23 September 2019.

Jenny sat on the panel and shared her passionate views about why people suffering from recurrent urinary tract infection – predominantly women – deserve better treatment (like the one that AtoCap is developing), and how it’s challenging to interact in the entrepreneurial space as a woman.

The host, Holly Branson of the Branson Virgin family, later remarked on her blog:

“Jennifer Rohn, a top scientist from AtoCap, has developed a new form of antibiotic delivery to treat disease and infections such as Urinary Tract Infections. Despite the complicated subject matter, Jennifer shared insight in a way that was easy to understand and even had the audience laughing!”

You can read more about the event here.

Back to news index